Price Wars
Novo Nordisk is fighting to hold on to market share in India as local firms push cheap weight-loss drugs
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.







